HeraMED Limited (ASX:HMD)
Australia · Delayed Price · Currency is AUD 0.0400
-0.0040 (-9.09%)
Feb 5, 2026, 4:10 PM AEST
HeraMED Market Cap
HeraMED has a market cap or net worth of 41.72 million as of February 5, 2026. Its market cap has increased by 140.80% in one year.
Market Cap
41.72M
Enterprise Value
40.77M
Revenue
322.93K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.04
Market Cap Chart
Since December 12, 2018, HeraMED's market cap has increased from 15.76M to 41.72M, an increase of 164.82%. That is a compound annual growth rate of 14.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 41.72M | 11.11% |
| Dec 31, 2025 | 37.55M | 114.42% |
| Dec 31, 2024 | 17.51M | 127.12% |
| Dec 29, 2023 | 7.71M | -74.58% |
| Dec 30, 2022 | 30.33M | -32.86% |
| Dec 31, 2021 | 45.18M | 173.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cleo Diagnostics | 90.33M |
| Compumedics | 78.91M |
| Micro-X | 63.89M |
| Nova Eye Medical | 52.69M |
| CleanSpace Holdings | 51.73M |
| ImpediMed | 46.89M |
| CurveBeam AI | 38.36M |
| Atomo Diagnostics | 30.79M |